Cargando…

Evaluation of retinal function improvement in neovascular age-related macular degeneration after intravitreal aflibercept injections with the use of the assessment of retinal sensitivity: The use of the assessment of retinal sensitivity in anti-VEGF treatment – a STROBE-compliant observational study

This study compares 2 methods of macular function evaluation: the microperimetric examination (mean central retinal sensitivity and fixation stability) and the distance best-corrected visual acuity (BCVA) examination, which is the most frequently used method of assessing macular function in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalska-Małecka, Katarzyna, Kałużny, Jakub, Nowak, Mariusz, Gościniewicz, Poitr, Matysik-Woźniak, Anna, Nowomiejska, Katarzyna, Karpe, Jacek, Rejdak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946441/
https://www.ncbi.nlm.nih.gov/pubmed/31689763
http://dx.doi.org/10.1097/MD.0000000000017599
_version_ 1783485363693551616
author Michalska-Małecka, Katarzyna
Kałużny, Jakub
Nowak, Mariusz
Gościniewicz, Poitr
Matysik-Woźniak, Anna
Nowomiejska, Katarzyna
Karpe, Jacek
Rejdak, Robert
author_facet Michalska-Małecka, Katarzyna
Kałużny, Jakub
Nowak, Mariusz
Gościniewicz, Poitr
Matysik-Woźniak, Anna
Nowomiejska, Katarzyna
Karpe, Jacek
Rejdak, Robert
author_sort Michalska-Małecka, Katarzyna
collection PubMed
description This study compares 2 methods of macular function evaluation: the microperimetric examination (mean central retinal sensitivity and fixation stability) and the distance best-corrected visual acuity (BCVA) examination, which is the most frequently used method of assessing macular function in patients with newly diagnosed wet age-related macular degeneration (AMD) who have been treated with anti-vascular endothelial growth factor (VEGF) drug (aflibercept). Prospective analysis was conducted on 44 eyes of 44 patients treated with intravitreal injection of anti-VEGF (aflibercept) because of newly diagnosed neovascular AMD. According to the research protocol, all patients had a 6-month follow-up. The response to treatment was monitored functionallybyMP-1 microperimetry, fixation, and distance BCVA assessment after injection. Improvement of retinal sensitivity and BCVA was found under aflibercept treatment. There was statistically significant improvement in retinal sensitivity in the MP-1 study 3 and 6 months from the beginning of anti-VEGF therapy. Moreover, a significant improvement in retinal sensitivity between 3 and 6 months of observation was demonstrated. At the same time, up to 3 months from the beginning of treatment, BCVA improved significantly compared to the baseline value. In the 6th month of the study BCVA remained stable without further significant improvement. Microperimetric examination with medium sensitivity and fixation stability assessment is a very valuable test determining the retinal function. It is clear that examining the macular morphology itself in modern diagnostics is not enough to assess retinal function. Microperimetry technique is a valuable tool for functional long-term evaluation of retinal function (also for a period of more than 3 months).
format Online
Article
Text
id pubmed-6946441
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-69464412020-01-31 Evaluation of retinal function improvement in neovascular age-related macular degeneration after intravitreal aflibercept injections with the use of the assessment of retinal sensitivity: The use of the assessment of retinal sensitivity in anti-VEGF treatment – a STROBE-compliant observational study Michalska-Małecka, Katarzyna Kałużny, Jakub Nowak, Mariusz Gościniewicz, Poitr Matysik-Woźniak, Anna Nowomiejska, Katarzyna Karpe, Jacek Rejdak, Robert Medicine (Baltimore) 5800 This study compares 2 methods of macular function evaluation: the microperimetric examination (mean central retinal sensitivity and fixation stability) and the distance best-corrected visual acuity (BCVA) examination, which is the most frequently used method of assessing macular function in patients with newly diagnosed wet age-related macular degeneration (AMD) who have been treated with anti-vascular endothelial growth factor (VEGF) drug (aflibercept). Prospective analysis was conducted on 44 eyes of 44 patients treated with intravitreal injection of anti-VEGF (aflibercept) because of newly diagnosed neovascular AMD. According to the research protocol, all patients had a 6-month follow-up. The response to treatment was monitored functionallybyMP-1 microperimetry, fixation, and distance BCVA assessment after injection. Improvement of retinal sensitivity and BCVA was found under aflibercept treatment. There was statistically significant improvement in retinal sensitivity in the MP-1 study 3 and 6 months from the beginning of anti-VEGF therapy. Moreover, a significant improvement in retinal sensitivity between 3 and 6 months of observation was demonstrated. At the same time, up to 3 months from the beginning of treatment, BCVA improved significantly compared to the baseline value. In the 6th month of the study BCVA remained stable without further significant improvement. Microperimetric examination with medium sensitivity and fixation stability assessment is a very valuable test determining the retinal function. It is clear that examining the macular morphology itself in modern diagnostics is not enough to assess retinal function. Microperimetry technique is a valuable tool for functional long-term evaluation of retinal function (also for a period of more than 3 months). Wolters Kluwer Health 2019-11-01 /pmc/articles/PMC6946441/ /pubmed/31689763 http://dx.doi.org/10.1097/MD.0000000000017599 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 5800
Michalska-Małecka, Katarzyna
Kałużny, Jakub
Nowak, Mariusz
Gościniewicz, Poitr
Matysik-Woźniak, Anna
Nowomiejska, Katarzyna
Karpe, Jacek
Rejdak, Robert
Evaluation of retinal function improvement in neovascular age-related macular degeneration after intravitreal aflibercept injections with the use of the assessment of retinal sensitivity: The use of the assessment of retinal sensitivity in anti-VEGF treatment – a STROBE-compliant observational study
title Evaluation of retinal function improvement in neovascular age-related macular degeneration after intravitreal aflibercept injections with the use of the assessment of retinal sensitivity: The use of the assessment of retinal sensitivity in anti-VEGF treatment – a STROBE-compliant observational study
title_full Evaluation of retinal function improvement in neovascular age-related macular degeneration after intravitreal aflibercept injections with the use of the assessment of retinal sensitivity: The use of the assessment of retinal sensitivity in anti-VEGF treatment – a STROBE-compliant observational study
title_fullStr Evaluation of retinal function improvement in neovascular age-related macular degeneration after intravitreal aflibercept injections with the use of the assessment of retinal sensitivity: The use of the assessment of retinal sensitivity in anti-VEGF treatment – a STROBE-compliant observational study
title_full_unstemmed Evaluation of retinal function improvement in neovascular age-related macular degeneration after intravitreal aflibercept injections with the use of the assessment of retinal sensitivity: The use of the assessment of retinal sensitivity in anti-VEGF treatment – a STROBE-compliant observational study
title_short Evaluation of retinal function improvement in neovascular age-related macular degeneration after intravitreal aflibercept injections with the use of the assessment of retinal sensitivity: The use of the assessment of retinal sensitivity in anti-VEGF treatment – a STROBE-compliant observational study
title_sort evaluation of retinal function improvement in neovascular age-related macular degeneration after intravitreal aflibercept injections with the use of the assessment of retinal sensitivity: the use of the assessment of retinal sensitivity in anti-vegf treatment – a strobe-compliant observational study
topic 5800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946441/
https://www.ncbi.nlm.nih.gov/pubmed/31689763
http://dx.doi.org/10.1097/MD.0000000000017599
work_keys_str_mv AT michalskamałeckakatarzyna evaluationofretinalfunctionimprovementinneovascularagerelatedmaculardegenerationafterintravitrealafliberceptinjectionswiththeuseoftheassessmentofretinalsensitivitytheuseoftheassessmentofretinalsensitivityinantivegftreatmentastrobecompliantobservationalstu
AT kałuznyjakub evaluationofretinalfunctionimprovementinneovascularagerelatedmaculardegenerationafterintravitrealafliberceptinjectionswiththeuseoftheassessmentofretinalsensitivitytheuseoftheassessmentofretinalsensitivityinantivegftreatmentastrobecompliantobservationalstu
AT nowakmariusz evaluationofretinalfunctionimprovementinneovascularagerelatedmaculardegenerationafterintravitrealafliberceptinjectionswiththeuseoftheassessmentofretinalsensitivitytheuseoftheassessmentofretinalsensitivityinantivegftreatmentastrobecompliantobservationalstu
AT gosciniewiczpoitr evaluationofretinalfunctionimprovementinneovascularagerelatedmaculardegenerationafterintravitrealafliberceptinjectionswiththeuseoftheassessmentofretinalsensitivitytheuseoftheassessmentofretinalsensitivityinantivegftreatmentastrobecompliantobservationalstu
AT matysikwozniakanna evaluationofretinalfunctionimprovementinneovascularagerelatedmaculardegenerationafterintravitrealafliberceptinjectionswiththeuseoftheassessmentofretinalsensitivitytheuseoftheassessmentofretinalsensitivityinantivegftreatmentastrobecompliantobservationalstu
AT nowomiejskakatarzyna evaluationofretinalfunctionimprovementinneovascularagerelatedmaculardegenerationafterintravitrealafliberceptinjectionswiththeuseoftheassessmentofretinalsensitivitytheuseoftheassessmentofretinalsensitivityinantivegftreatmentastrobecompliantobservationalstu
AT karpejacek evaluationofretinalfunctionimprovementinneovascularagerelatedmaculardegenerationafterintravitrealafliberceptinjectionswiththeuseoftheassessmentofretinalsensitivitytheuseoftheassessmentofretinalsensitivityinantivegftreatmentastrobecompliantobservationalstu
AT rejdakrobert evaluationofretinalfunctionimprovementinneovascularagerelatedmaculardegenerationafterintravitrealafliberceptinjectionswiththeuseoftheassessmentofretinalsensitivitytheuseoftheassessmentofretinalsensitivityinantivegftreatmentastrobecompliantobservationalstu